Monday, September 25, 2017

Review Finds Little Evidence that Electroconvulsive Therapy is Effective for Depression

Researchers examined the dearth of support for Electroconvulsive therapy (ECT) for depressive symptoms in light of studies detailing the associated risks.

More Follow Up Needed for Drugs Granted Accelerated FDA Approval

Drugs to treat serious or life-threatening conditions can receive accelerated FDA approval, but may expose patients to increased safety risks and reduced efficacy.

A Blow to STAT’s Credibility: Ghostwriting/PR Influence

From HealthNewsReview.org: STAT recently published an op-ed praising the role of drug company sales representatives. The physician listed as the author has now revealed that he did...

The Most Promoted Drugs are Those with Little Therapeutic Value, Study Finds

Majority of top-selling and most promoted drugs in Canada are rated as having very limited safety and efficacy.

Silicon Valley Courts Brand-Name Teachers, Raising Ethics Issues

From The New York Times: Tech companies are increasingly recruiting school teachers to help improve and promote their education tools in exchange for perks, including...

Has the Era of Gene Therapy Finally Arrived?

From Scientific American: The FDA has announced its approval of Kymriah, the first gene therapy in the U.S. However, gene therapy remains far from fulfilling...

Proove Biosciences Sells Off Assets as CEO Departs

From STAT: Proove Biosciences, which sold dubious DNA tests to predict opioid addiction risk, has been placed into court-ordered receivership for restructuring and asset sale. Experts...

MDMA Crossed a Hurdle on the Path to Being Legally Prescribed

From Yahoo! Finance: The Multidisciplinary Association for Psychedelic Studies (MAPS) has passed a major hurdle on the path to getting MDMA approved for medical use....

The State of the Evidence Base for Current Medical Products

In this post for Yale Law School's CRITical Thinking, Tom Jefferson discusses some of the factors that currently serve to undermine rational and ethical medical...

Biotech Exploits a Loophole in a Federal Transparency Law

From STAT: A small biotech company, AveXis, recently offered a $3,000 honorarium along with paid airfare and lodging to several experts to attend a so-called...

Pharma ‘Getting Away With Murder’ Abroad Thanks to Trump

From STAT: Despite accusing the pharmaceutical industry of "getting away with murder" by charging high drug prices, President Trump is now giving drug companies more power...

Researchers Question the “Adequacy and Legitimacy” of ADHD Diagnosis

A new article, just published online in the journal Emotional and Behavioural Difficulties, presents research suggesting that the diagnosis of ADHD is philosophically inadequate.

FDA Seeks Input on Drug Risk Information in Broadcast Ads

From FDA in Brief: The FDA seeks input from consumers and medical professionals on making sure the drug risk information in statements included in direct-to-consumer...

Trust Falls – Are We in a New Phase of Corporate Research?

From The Scholarly Kitchen: We may be in a new phase of corporation-funded research. According to the 2016 Science & Engineering Indicators from the National...

A Supreme Court Pharma Case Deals Consumers a Big Loss

From STAT: The U.S. Supreme Court case of Bristol-Meyers Squibb Co. vs. Superior Court of California, in which hundreds of plaintiffs claimed the drug Plavix...

Vanda Puts Antipsychotic Side Effect Front and Center in TV Ads

From FiercePharma: Vanda Pharmaceuticals, which makes the antipsychotic drug Fanapt, has recently rolled out a national TV campaign to raise awareness of akathisia. The company...

Newly-Revised List of Industry-Independent Experts for Journalists

From HealthNewsReview: For nine years, HealthNewsReview has hosted a one-of-a-kind list of health care industry-independent experts for journalists. The list has now been revised with new...

Ethical Failings in Experimental Drug Safety Trials

Leading human subjects ethics researcher questions exploitation of uninsured minorities in experimental drug trials.

Dr. Joel Lexchin Says Big Pharma is too Close With Physicians

From The Toronto Star: In his new book Doctors in Denial: Why Big Pharma and the Canadian Medical Profession are too Close for Comfort, Dr. Joel...

There’s Little Evidence Abuse-Deterrent Opioids Work

From STAT: In recent years, the pharmaceutical industry has proposed using abuse-deterrent opioids - those that make it more difficult to crush, snort, or inject...

Patients With Schizophrenia Show Better Work Functioning Off Antipsychotics

20-year follow-up study finds that after four years, patients not prescribed antipsychotics have significantly better work functioning.

Researchers Find Inadequate Reporting of the Dangers of Ketamine Treatment for Depression

Researchers report that dangerous side effects are not being adequately reported in the trials of ketamine for depression.

As Cost of Health Care Skyrockets, So Does Pay of CEOs

From NPR: In the seven years since the Affordable Care Act was passed, the earnings of CEOs of U.S. health care companies, including pharmaceutical companies,...

The Moving Basis of Mental Health Diagnosis

In this opinion piece for The Chronicle Herald, Dr. A.J. discusses the subjective nature of psychiatric diagnosis and the DSM. Citing research by Paula Kaplan,...

DARPA Wants to Build a BS Detector for Science

From Wired: A new grant from DARPA will fund research into ways to determine which research from the social and behavioral sciences is credible, and which has flawed methodology...

Follow Us

19,372FansLike
10,223FollowersFollow
1,373SubscribersSubscribe